Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALA for Visualization and Resection of Brain Tumors
NCT01116661Phase 2Terminated
- Sponsor
- University of California, San Francisco
- Start
- Aug 2010
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of 5-aminolevulinic acid in glioma, sponsored by University of California, San Francisco. Primary endpoint: Percentage of Biopsies Taken From the Most Fluorescent Tissues That Have Tumorous Content at 1 day. Started Aug 2010; status: terminated.
02
Drugs
5-aminolevulinic acid
03
Conditions
glioma
Beyond the preview
Go deeper on NCT01116661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01116661.